OTX015 dose for lymphoma narrowed in phase 1 studyApril 10, 2016Indolent LymphomaAggressive Lymphomas
Temsirolimus results in good but short-duration responses in primary CNS lymphomaMarch 14, 2016Aggressive Lymphomas
Follicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvementMarch 10, 2016Indolent Lymphoma
Expert panel issues guidelines for treatment of hematologic cancers in pregnancyDecember 1, 2015Aggressive LymphomasIndolent Lymphoma
Medical Roundtable: Pediatric Non-Hodgkin Lymphoma (NHL) Classification Guidelines - International Pediatric NHL Staging System (IPNHLSS)November 25, 2015Aggressive Lymphomas
New therapies finding their place in management of follicular lymphomaNovember 5, 2015Indolent Lymphoma
Medical Roundtable: Hodgkin Lymphoma - Discussing Recent Evidence & Practice OptionsOctober 19, 2015Indolent LymphomaAggressive Lymphomas
Routine imaging for diffuse large B-cell lymphoma offers no survival benefitOctober 5, 2015Aggressive Lymphomas
Obinutuzumab trends better than rituxumab in relapsed indolent lymphomaSeptember 3, 2015Indolent Lymphoma
Lenalidomide + rituximab combo effective in recurrent follicular lymphomaAugust 24, 2015Indolent Lymphoma
